Nexium for aspirin-induced ulcers among new indications approved in Japan
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has approved a number of products for additional indications, including AstraZeneca's Nexium (esomeprazole) for the prevention of recurrence of gastric and duodenal ulcers in patients being treated with low doses of acetylsalicylic acid.